PD-0575: The dosimetrical advantage of prone position on a bellyboard for rectal cancer: does it still hold with VMAT?  by Verstraete, J. et al.
3rd ESTRO Forum 2015                                                                                                                                         S281 
 
irregular and curved surfaces can significantly alter the dose 
distribution. A better understanding of these effects is 
necessary to assess target coverage in pelvic IOERT, and 
interpret any in vivo measurements. 
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Purpose/Objective: The aim was to evaluate whether prone 
position on a belly board for rectal cancer radiotherapy is 
still beneficial when highly-conformal volumetric modulated 
arc therapy (VMAT) is applied. Additionally, the feasibility of 
moderate dose escalation with VMAT was investigated. 
Materials and Methods: Eleven patients with stage II/III 
rectal cancer were prospectively enrolled. Each patient 
underwent a planning CT in both prone and supine position. 
For prone positioning, a belly board was used (MacroMedics® 
Pelvic Prone BoardTM).  
To evaluate the dosimetrical benefit of prone vs. supine 
position, VMAT plans (2 arcs of 358°) were created for both 
treatment positions. A dose of 45 Gy in 25 fractions was 
prescribed. Plans were considered acceptable if ≥95% of the 
planning target volume (PTV) received ≥95% of the prescribed 
dose and if Dmax was ≤107% of the prescribed dose. For 
comparison of prone and supine, an average DVH over all 
patients was created by calculating for each structure the 
mean relative volume in 10 cGy absolute dose bins.  
To investigate the feasibility of moderate dose escalation, 
only the prone scans were used and 3D-conformal 
radiotherapy (3D-CRT) plans (45 Gy in fractions of 1.8 Gy) 
were compared with VMAT plans (50 Gy in fractions of 2 Gy). 
The homogeneity index (HI) of the PTV was defined as [(D2-
D98)/Dprescribed x 100] and the conformity index (CI) as 
V95/PTVvolume. Statistical analyses were performed using the 
Wilcoxon signed-rank test; a p-value ≤ 0.05 was considered 
statistically significant.  
Results: While the PTV parameters were similar, prone 
positioning reduced the V15 of the small bowel (median 64.4 
cc vs. 194.8 cc; p = 0.008), the V15 of the large bowel 
(median 38.5 cc vs. 71.3 cc; p = 0.006) and the V15 of the 
bowel bag (median 433.4 cc vs. 762.2 cc; p = 0.003) 
compared to supine using VMAT (Table 1). The V45 of all 
bowel structures was also lower in prone position, but this 
was not statistically significant. 
Moderate VMAT dose escalation up to 50 Gy does not lead to 
an increased dose to the organs at risk compared to 3D-CRT 
up to 45 Gy. The V15 of the bowel bag and the V40 of the 
bladder were significantly lower with VMAT 50 Gy compared 
to 3D-CRT 45 Gy (median 445.2 cc vs. 562.6 cc, p = 0.003; 
median 32.8 cc vs 47.1 cc; p = 0.003 respectively). 3D-CRT 
plans had a higher CI compared to VMAT (median 1.00 vs. 
0.96; p = 0.003). The PTV dose homogeneity was better in 
the 3D-CRT plans compared to the VMAT plans (median 8.13 
vs. 9.48; p = 0.006).  
 
 
 
Conclusions: Even with highly-conformal radiotherapy 
techniques as VMAT, prone position with belly board remains 
beneficial for the dose to the bowel structures. Moderate 
dose escalation with VMAT up to 50 Gy does not increase the 
V15 and V45 of the bowel structures compared to 3D-CRT up 
to 45 Gy.  
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Purpose/Objective: To quantify and to assess the dosimetric 
significance of rotational displacements in head and neck 
patients planned with VMAT, in order to establish a process 
development pathway for the management of rotational 
displacements. 
Materials and Methods: Initial quality assurance of the 
commercially available IGRT software (OBITM) was performed. 
Varying permutations of the offline auto match process and 
weightings (Volume of Interest (VOI), Structure VOI (sVOI) 
and Intensity Range) were assessed in Six degrees of freedom 
(6DoF), in order to determine the optimum method for 
rotational quantification across twelve patients with various 
tumour sites. To determine thresholds of dosimetric impact 
for rotational setup errors, simulated rotational 
displacements were created on the Planning CT images (PCT) 
for each patient. Using commercially available software 
(MIMS TM) the PCT images were rotated around the isocentre 
incrementally from 1 to 5 degrees – this was done for 
combined and single axis rotational displacements. The 
manipulated image sets were then exported back to the 
ECLIPSETM treatment planning system to determine the 
dosimetric consequences of rotations on both the PTV and 
the Organs At Risk (OAR). 
Results: Regardless of Intensity Range employed, results 
demonstrate that using PTV as the sVOI is preferential 
compared to using OAR sVOI or matching without the 
inclusion of rotations (Table 1). On the virtually rotated PCT 
images, both combined and single axis simulations 
demonstrated more variance in dose to the OAR when 
compared with PTV. D98% for the PTV showed noticeable 
difference when compared to the PCT, varying by 11.3% and 
13.3% for combined rotations of +3 and -3 degrees, 
respectively. D2% for the PTV showed little or no variation 
(Figure 1A). Spinal Cord Planning Organ at Risk Volume (PRV) 
(3mm margin) showed the most noticeable dose difference 
with D1cc variation of 15.54% and 12.65% at combined 
rotations of +/-1 degree, respectively. Spinal cord (SC) is 
